SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: StockMiser who wrote (14)1/28/1999 2:28:00 PM
From: Street Walker   of 5582
 
The $24 target does not include ZICAM

It will take time to figure out how much ZICAM
will add to their bottom line before they
can establish a new price target.

I would also suspect other firms are number
crunching figures to determine the prospects
of Zicam and price target for GUMM. After this
is done, BIG MONEY will move in.

This same phenomenon occurred when PFE released Viagra.
It took a few days for brokerage firms to analyze its potential.

Regards,
S.W.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News